Wrocław Medical University is an institution of higher medical education in Wrocław, Poland. It consists of five faculties: Medicine, Dentistry, Pharmacy, Public Health and Postgraduate Education. The total number of chairs and clinics is 107.

During the past decade, Dpt. SCT and Hematology/Oncology University Wroclaw conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dpt. SCT and Hematology/Oncology University Wroclaw" #1 collaborator was "Australian & New Zealand Children's Haematology/Oncology Group" with 2 trials as a collaborator, "Centre Hospitalier Universitaire de Nice" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "Medical University of Wroclaw (Co-Sponsor Poland)" with 2 trials as a collaborator and "Our Lady's Chilrden's Hospital (Co-Sponsor Ireland)" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Dpt. SCT and Hematology/Oncology University Wroclaw" are "Acute Lymphoblastic Leukemia (ALL)" (2 trials). Many other conditions were trialed in "Dpt. SCT and Hematology/Oncology University Wroclaw" in a lesser frequency.

Most popular intervention types in "Dpt. SCT and Hematology/Oncology University Wroclaw" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (1 trials), "SR-A + Epratuzumab" (1 trials) and "SR-B + Epratuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dpt. SCT and Hematology/Oncology University Wroclaw" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dpt. SCT and Hematology/Oncology University Wroclaw". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Dpt. SCT and Hematology/Oncology University Wroclaw, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dpt. SCT and Hematology/Oncology University Wroclaw, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".